| Financial Year |
March 31 2023 |
| Monetary Funds |
769,212,442.36 |
| Held-for-trading Financial Assets |
779,618.41 |
| Notes Receivable |
22,673,970.91 |
| Accounts Receivable |
1,759,777,571.50 |
| Advances to Suppliers |
34,640,702.86 |
| Other Receivables |
38,858,143.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
950,099,600.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
68,828,926.69 |
| Total Current Assets |
3,717,594,617.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
47,078,460.68 |
| Investment Properties |
2,269,124.86 |
| Fixed Assetes |
1,152,568,515.02 |
| Under-construction Projects |
355,451,275.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
240,058,105.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,020,472.83 |
| Deferred Income Tax Assets |
42,891,478.95 |
| Other Non-Current Assets |
287,244,825.89 |
| Sub-Total of Non-Current Assets |
2,204,379,016.75 |
| Total Assets |
5,921,973,634.58 |
| Short-Term Loans |
1,262,169,805.56 |
| Trading Financial liabilities |
425,100.00 |
| Notes Payable |
386,900,000.00 |
| Accounts Payable |
182,751,660.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,205,311.54 |
| Taxes Payable |
24,704,586.46 |
| Interest Payable |
-- |
| Dividend Payable |
20,353.10 |
| Other payables |
38,434,762.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
281,009,979.23 |
| Other Current Liabilities |
50,875,853.28 |
| Sub-Total of Current Liabilities |
2,631,455,468.41 |
| Long-term Loans |
990,462,382.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,087,069,032.25 |
| Total Liabilities |
3,718,524,500.66 |
| Paid-In Capital(Or Share Stock) |
656,667,000.00 |
| Capital Surplus |
347,028,654.03 |
| Surplus Reserve |
239,807,542.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
540,641,305.99 |
| Minority Stockholder's Interest |
377,687,844.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,825,761,289.11 |
| Owner's Equity（Stockholder's Equity） |
2,203,449,133.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,921,973,634.58 |
